Corrigendum: Case Series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequalae of COVID (PASC)

Affiliations

• ¹ IncellDX Inc., San Carlos, CA, United States.
• ² Department of Anesthesiology, Beth Israel Lahey Health, Burlington, MA, United States.
• ³ Centro de Investigación en Cirugía y Cáncer (CICICA), Universidad de Costa Rica, San Jose, Costa Rica.
• ⁴ Lab of Tumor Chemosensitivity, CIET/DC Lab, Faculty of Microbiology, Universidad de Costa Rica, San Jose, Costa Rica.
• ⁵ Department of Medicine, St. Francis Medical Center, Trenton, NJ, United States.
• ⁶ Department of Emergency Medicine, Novant Health Kernersville Medical Center, Kernersville, NC, United States.
• ⁷ Department of Allergy and Immunology, NYU Langone Tisch Hospital, New York, NY, United States.
• ⁸ Department of Emergency Medicine, New York Presbyterian Hospital, Brooklyn, NY, United States.
• ⁹ Department of Anesthesiology, Stamford Hospital, Stamford, CT, United States.
• ¹⁰ Rutland Medical Group, Newport Beach, CA, United States.
• ¹¹ Department of Community and Family Medicine, Georgetown University Medical Center, Washington, DC, United States.
• ¹² Department of Medicine, Creighton University School of Medicine, Phoenix, AZ, United States.